Reservoir Neuroscience secures **$4 million in financing** to advance its **new therapies for age-related neurodegeneration**. The Emeryville, CA-based company develops treatments targeting neurodegenerative conditions linked to aging. This funding supports further research and development in the field.
Kizoo leads a **$4 million financing round** for **Reservoir Neuroscience** to advance therapies targeting age-related neurodegeneration. The funding supports research into restoring brain health in aging populations. Reservoir Neuroscience focuses on developing interventions for neurodegenerative conditions linked to aging.
Kizoo leads a **$4 million funding round** for **Reservoir Neuroscience**, a San Francisco-based biotech focused on restoring brain health in aging populations. The company aims to develop therapies targeting neurodegenerative diseases through its research platform. Reservoir’s work centers on reversing age-related cognitive decline and related conditions.
SynapCell and Reservoir Neuroscience collaborate to evaluate drug candidates in a **pharmaco-resistant mesial temporal lobe epilepsy (MTLE)** model. The partnership targets treatment for patients with chronic epilepsy who do not respond to existing therapies. Both companies focus on advancing neuroscience solutions for unmet clinical needs.
